Explore FHI 360

163 Results Found

  • Practice Area
    There is an art to improving lives. And it’s in our science.
  • Feature
    In Nigeria, the Akwa Ibom AIDS Indicator Survey (AKAIS) generated more accurate data than previously available. The data will be used to improve Akwa Ibom State’s response to HIV.
  • News
    Dr. Timothy Mastro, Chief Science Officer, describes his top picks from the latest published research from FHI 360.
  • Publication
    This fact sheet summarizes the research agenda being implemented under Envision FP, a five-year contraceptive research award funded by the U.S. Agency for International Development.
  • Feature
    In this audio interview, Ted FitzGerald and Claudia Christian discuss the global community’s preparedness for the next pandemic and the lessons we have learned about rapidly setting up clinical trials in resource-limited countries.
  • External Article
    Among several new options for male contraceptives mentioned in this article is Gendarussa, a product that prevents sperm from fertilizing an egg. FHI 360 developed protocols for the next phase of clinical trial for this product. Paul Feldblum, FHI 360 Senior Epidemiologist, says Gendarussa received clearance from the Indonesian equivalent of the U.S. Food and Drug Administration to proceed with Phase 2 trials.
  • News
    FHI 360 is providing monitoring services for a trial to evaluate a DNA vaccine for the Zika virus, which could protect healthy adults and adolescents.
  • Published research
    Safety and tolerability of maraviroc-containing regimens to prevent HIV infection in women: A phase 2 randomized trial
    This study shows that, for U.S. women at risk of HIV infection, pre-exposure prophylaxis (PrEP) regimens containing maraviroc are safe and well-tolerated, compared with the standard regimen of tenofovir disoproxil fumarate/emtricitabine. The authors also found that no new infections occurred with the study regimen, compared with the standard regimen, but more research is needed to determine whether that outcome is because of the study drug and whether the enrolled population was lower risk than anticipated.
  • Published research
    Electronic health, telemedicine and new paradigms for training and care
    This qualitative literature review assesses eHealth and mHealth training methods for HIV care that were published between 2016 and 2017. Notable findings were that the merging of electronic medical records systems improved telemedicine through mobile networks and instant messaging services to low-resource areas, and that few trials established efficient strategies to train HIV care providers or extenders on HIV care outcomes. The authors recommend more rigorous testing of electronic training interventions to demonstrate the impact on services for people living with HIV.
  • Published research
    HIV treatment cascade among female entertainment and sex workers in Cambodia: Impact of amphetamine use and an HIV prevention program
    This study examines the continuum-of-care outcomes among HIV-positive, female, entertainment sex workers in Cambodia. While most women were successfully linked to HIV care, the authors found that retention and viral suppression were low. The authors suggest that tailored existing HIV/AIDS prevention programs that target the broader population of HIV-positive, female, entertainment sex workers, as well as interventions to reduce amphetamine-type stimulant use, could optimize the health benefits of HIV treatment.